Literature DB >> 25015331

Overall survival benefit from surgical resection in treatment of recurrent glioblastoma.

B S Mann1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 25015331      PMCID: PMC4155469          DOI: 10.1093/annonc/mdu243

Source DB:  PubMed          Journal:  Ann Oncol        ISSN: 0923-7534            Impact factor:   32.976


× No keyword cloud information.
  5 in total

1.  Is surgery at progression a prognostic marker for improved 6-month progression-free survival or overall survival for patients with recurrent glioblastoma?

Authors:  Jennifer L Clarke; Michele M Ennis; W K Alfred Yung; Susan M Chang; Patrick Y Wen; Timothy F Cloughesy; Lisa M Deangelis; H Ian Robins; Frank S Lieberman; Howard A Fine; Lauren Abrey; Mark R Gilbert; Minesh Mehta; John G Kuhn; Kenneth D Aldape; Kathleen R Lamborn; Michael D Prados
Journal:  Neuro Oncol       Date:  2011-08-02       Impact factor: 12.300

2.  Benefit of tumor resection for recurrent glioblastoma.

Authors:  Johanna Quick; Florian Gessler; Stephan Dützmann; Elke Hattingen; Patrick N Harter; Lutz M Weise; Kea Franz; Volker Seifert; Christian Senft
Journal:  J Neurooncol       Date:  2014-02-15       Impact factor: 4.130

3.  An extent of resection threshold for recurrent glioblastoma and its risk for neurological morbidity.

Authors:  Mark E Oppenlander; Andrew B Wolf; Laura A Snyder; Robert Bina; Jeffrey R Wilson; Stephen W Coons; Lynn S Ashby; David Brachman; Peter Nakaji; Randall W Porter; Kris A Smith; Robert F Spetzler; Nader Sanai
Journal:  J Neurosurg       Date:  2014-01-31       Impact factor: 5.115

4.  New prognostic factors and calculators for outcome prediction in patients with recurrent glioblastoma: a pooled analysis of EORTC Brain Tumour Group phase I and II clinical trials.

Authors:  Thierry Gorlia; Roger Stupp; Alba A Brandes; Roy R Rampling; Pierre Fumoleau; Christian Dittrich; Mario M Campone; Chris C Twelves; Eric Raymond; Monika E Hegi; Denis Lacombe; Martin J van den Bent
Journal:  Eur J Cancer       Date:  2012-03-28       Impact factor: 9.162

5.  Impact of extent of resection for recurrent glioblastoma on overall survival: clinical article.

Authors:  Orin Bloch; Seunggu J Han; Soonmee Cha; Matthew Z Sun; Manish K Aghi; Michael W McDermott; Mitchel S Berger; Andrew T Parsa
Journal:  J Neurosurg       Date:  2012-10-05       Impact factor: 5.115

  5 in total
  2 in total

1.  Re-resection for recurrent high-grade glioma in the setting of re-irradiation: more is not always better.

Authors:  Joshua D Palmer; Joshua Siglin; Kosj Yamoah; Tu Dan; Colin E Champ; Voichita Bar-Ad; Maria Werner-Wasik; James J Evans; Lyndon Kim; Jon Glass; Christopher Farrell; David W Andrews; Wenyin Shi
Journal:  J Neurooncol       Date:  2015-05-30       Impact factor: 4.130

2.  Patient-derived glioblastoma stem cells respond differentially to targeted therapies.

Authors:  Pratik Kanabur; Sujuan Guo; Gary R Simonds; Deborah F Kelly; Robert G Gourdie; Scott S Verbridge; Zhi Sheng
Journal:  Oncotarget       Date:  2016-12-27
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.